Rehovot, Israel
September 3, 2014

Dr. Alan Shackelford, Head of the Scientific Advisory Board for BreedIT was recently interviewed by CEOLIVE.TV and discussed why BreedIT will become a key player in the medical cannabis Industry.

In the interview, Dr. Shackelford discusses many topics, including BreedIT's collaboration with Hebrew University of Jerusalem and BreedIT's unique position in the emerging marijuana industry as a company at the forefront of the technology that combines academia and practical experience to selectively produce targeted strains of cannabis with specific therapeutic implications. Dr. Shackelford also details why the location of BreedIT's subsidiary in Israel, often called the medical research capital of the world, is significant on a global scale to advance cannabis research on various levels. "I am very pleased that Dr. Shackelford participated in this interview as I think it is paramount to inform shareholders and all interested parties about the impact potential of BreedIT and its IDSS software and technology on the cannabis industry," commented Mr. Itschak Schrem, Chaiman of BreedIT Corp. "This is a proven technology developed by academic leaders that can shave years off the very onerous task of identifying and breeding specific traits into cannabis, whether for medicinal or industrial purposes. Dr. Shackelford's extensive clinical knowledge coupled with his deep understanding of the industry in general, delivers the message in a concise manner as to why what we are doing is so compelling."

BreedIT Corp., through its Israeli subsidiary, BreedIT Ltd., is the developer of highly sophisticated agro-breeding solutions for plant breeders and researchers. BreedIT's proven iBreedIT® - Intelligent Decision Support System (IDSS) for breeders, which was developed by a team consisting of among the world's leading breeding specialists for optimizing the breeding processes, services the plant breeding needs of corporations, research and government institutions. BreedIT's IDSS provides advanced solutions for generating and disseminating knowledge aimed at assisting breeders to plan, manage and analyze their breeding data and to perform research activities quickly and effectively. Founded in 2013, BreedIT Corp has offices in New York and in Rehovot, Israel.

BreedIT Corp. trades on the OTCQB under ticker symbol BRDT.

Website: http://www.ibreedit.com

Published: September 3, 2014